🧾 What This Document Is

This is Medifast's Definitive Proxy Statement (DEF 14A). Think of it as a formal invitation and information packet for the company's annual shareholder meeting. Its main job is to ask shareholders to vote on important company matters. The meeting will be held in person on Tuesday, May 19, 2026, at 4:30 p.m. ET in Baltimore, MD.

🏢 What The Company Does

👉 In simple terms, Medifast is the company behind the OPTA VIA brand. They sell weight management, healthy living, and metabolic health products through a network of independent coaches. It's a direct-selling business model, similar to a modern version of a salesforce.

📅 What You're Voting On (The 4 Proposals)

Shareholders will vote on four key items. The Board recommends a "FOR" vote on all of them.

Elect Directors: Vote to elect 7 board members for one-year terms. This includes re-electing 5 current directors and electing 2 new nominees, Parsa Kiai and Jeffrey Rose. Two longtime directors, Jeffrey Brown and Michael Hoer, are retiring.
Ratify the Auditors: Approve RSM US LLP as the company's independent accounting firm for 2026.
Advisory Vote on Pay (Say-on-Pay): Approve, on a non-binding basis, the compensation of the company's top executives.
Approve a New Incentive Plan: Approve the Amended and Restated 2012 Share Incentive Plan, which governs stock awards for employees and directors.

👉 Why it matters: These votes are your direct say in company governance—who oversees it, who checks the books, how much the bosses are paid, and how they use company stock to reward people.

👥 The Board in Transition

The board is undergoing a notable change. Daniel R. Chard currently serves as both Chairman and CEO. However, the company announced that effective June 1, 2026, he will transition to Non-Executive Chairman. This separates the Chairman and CEO roles. The board will also appoint a new Lead Independent Director after the meeting, as current Lead Director Jeffrey Brown is retiring.

🔍 Who's on the Board & Nominees

The board has 7 seats. Here’s a snapshot of the mix of experience:

Daniel R. Chard (61): CEO since 2016. Deep direct-selling and international operations experience.
Elizabeth A. Geary (45): Insurance and cyber risk expert.
Parsa Kiai (45) - New: Finance & investment expert from Steamboat Capital.
Jeffrey Rose (55) - New: Finance, legal, and risk expert, also from Steamboat Capital.
Scott Schlackman (68): Global direct-selling executive, formerly with Avon.
Andrea B. Thomas (61): Marketing and consumer goods veteran from Walmart, Hershey, and PepsiCo.
Ming Xian (62): Strategic management experience with a focus on Asia.

👉 The new nominees, Kiai and Rose, were nominated as part of a Cooperation Agreement with an investor called Steamboat Capital.

🏛️ How the Company is Governed

The board oversees the company through several committees:

Audit Committee: Checks financials and appoints the auditors (RSM US LLP).
Compensation Committee: Sets pay for top executives.
Nominating/Governance Committee: Recommends directors and oversees governance rules.
Executive Committee: Can act quickly on urgent matters between full board meetings.

The filing also details the company's focus on culture, employee development, wellness programs, and its diversity statistics (as of Dec 31, 2025: 50% of the board and executive officers are racially diverse or female).

💰 Executive Compensation Deep Dive

A large part of the document explains how the executives are paid. It's not just a salary. The package is designed to tie pay to company performance and stockholder returns. It includes:

Base Salary
Annual Cash Bonuses tied to specific financial and operational goals.
Long-Term Incentives (Stock Awards): These are the biggest part and are meant to reward long-term growth. They "vest" (are earned) over time, encouraging executives to stay and focus on future results.

The "Compensation Discussion & Analysis" (CD&A) section explains the philosophy behind each part of the pay plan.

📞 How to Vote & Key Dates

Record Date: You must own shares by the close of business on March 23, 2026, to vote.
Vote Before the Meeting: You can vote by Internet, phone, or mail before 11:59 p.m. ET on May 18, 2026. Even if you plan to attend, voting early is encouraged (you can change your vote later).
Vote at the Meeting: You can vote in person on May 19th, but you must bring proof of share ownership and valid photo ID.

🧠 The Analogy

Think of Medifast's annual meeting like a major league team's annual fan forum. The proxy statement is the agenda:

Proposal 1 (Directors) is like voting for the team's owners and board of governors.
Proposal 2 (Auditors) is like hiring the independent league that verifies all stats and finances are correct.
Proposal 3 (Pay) is a non-binding fan vote on whether the star players' contracts are fair.
Proposal 4 (Incentive Plan) decides the rules for how the team can give stock options or bonuses to players and staff. You, as a shareholder, are a partial owner of the team, and these votes shape its leadership, integrity, and direction.

🧩 Final Takeaway

This proxy statement is about governance and oversight during a transition. The key takeaways are the planned separation of the Chairman and CEO roles, the election of two new directors following an agreement with an investor, and shareholder votes on compensation and equity plans. It’s a blueprint for how Medifast plans to be directed and managed in the coming year.

MEDIFAST INC — DEF 14A Filing